US 11,299,518 B2Granted

Fusion respiratory syncytial virus inhibitors and use thereof

AssigneeFondation the Ark

InventorsOrigene Nyanguile, Jean-Manuel Segura, Dominique Garcin

Life of this patent

Estimating the term…

The present invention relates novel peptides useful for the prevention and/or treatment of respiratory syncytial virus (RSV) infections.

Dependent claims

A compound selected from the group consisting of SEQ ID NOs:

Dependencies are inferred from the claim text.

C07K 14/135
Paramyxoviridae, e.g. parainfluenza virus: respiratory syncytial virus
A61K 38/16
Medicinal preparations containing peptides: peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K 39/12
Medicinal preparations containing antigens or antibodies: viral antigens
A61P 31/14
Antivirals: for RNA viruses

From the US filing history. Foreign family members aren’t listed.

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

Loading patent…